ArticleEuropean urology open science2026

Real-world Outcomes of Adjuvant Nivolumab in High-risk Bladder and Upper Tract Urothelial Carcinoma after Radical Surgery.

Shunsuke Tazawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.